Novo Nordisk expects to turn its US growth up a notch, since the company is back to growing on this market after a stagnation and price pressure-riddled 2019.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Ambu credits MDR milestone to fastidiousness
All of Medtech firm Ambu’s products already live up to the new EU rules for medical devices, something the firm attributes to a good sense of how much effort living up to the new legislation would require.
Board chair at Coloplast and Lundbeck warns against large pay rises
Companies have a responsibility to help combat inflation by keeping pay rises in check during contract negotiations, says Lars Rasmussen.
Ellab slapped with customs fine over US imports
Danish medtech producer Ellab broke US customs rules and is now paying the price.
China approves Y-mabs drug
Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.
CEO gets "taste of own medicine" by participating in vaccine trial
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.
Medical Director 
Laboratory assistants for an exciting QC department 
Systems Verification Manager for Embedded Medical Solutions 
Director, QA Commercial Drug Substance, Ascendis Pharma 
Medical Manager Denmark & Norway 
Consultants for FIERS - will you create unique healthcare collaborations? - FIERS - Copenhagen / Denmark 
Specialist, Regulatory Affairs 
Chief consultant for Dansk Erhvervs Health and life science 
Supply Chain Manager 
Head of Engineering 
Senior or Principal Scientist – Preclinical Biology